Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P. trimmed its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,900 shares of the medical equipment provider’s stock after selling 225 shares during the quarter. Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P.’s holdings in Zimmer Biomet Holdings were worth $1,528,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of ZBH. Bridgecreek Investment Management LLC increased its holdings in shares of Zimmer Biomet Holdings by 39.1% in the first quarter. Bridgecreek Investment Management LLC now owns 32,115 shares of the medical equipment provider’s stock worth $3,922,000 after purchasing an additional 9,035 shares during the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Zimmer Biomet Holdings by 77.0% in the first quarter. Advisors Asset Management Inc. now owns 43,211 shares of the medical equipment provider’s stock worth $5,276,000 after purchasing an additional 18,797 shares during the last quarter. Flinton Capital Management LLC increased its holdings in shares of Zimmer Biomet Holdings by 12.4% in the first quarter. Flinton Capital Management LLC now owns 9,520 shares of the medical equipment provider’s stock worth $1,162,000 after purchasing an additional 1,054 shares during the last quarter. FTB Advisors Inc. increased its holdings in shares of Zimmer Biomet Holdings by 521.3% in the first quarter. FTB Advisors Inc. now owns 2,572 shares of the medical equipment provider’s stock worth $314,000 after purchasing an additional 2,158 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale increased its holdings in shares of Zimmer Biomet Holdings by 120.3% in the first quarter. DekaBank Deutsche Girozentrale now owns 134,569 shares of the medical equipment provider’s stock worth $16,414,000 after purchasing an additional 73,489 shares during the last quarter. 85.48% of the stock is currently owned by hedge funds and other institutional investors.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) traded down 0.28% on Friday, hitting $115.67. The stock had a trading volume of 444,496 shares. Zimmer Biomet Holdings, Inc. has a 12 month low of $95.63 and a 12 month high of $133.49. The stock has a market cap of $23.39 billion, a PE ratio of 32.95 and a beta of 1.21. The firm’s 50 day moving average price is $115.16 and its 200-day moving average price is $120.75.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.10 by ($0.02). The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The firm’s quarterly revenue was up 1.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.02 EPS. On average, analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.83%. Zimmer Biomet Holdings’s dividend payout ratio is currently 27.59%.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/15/holt-capital-advisors-l-l-c-dba-holt-capital-partners-l-p-trims-stake-in-zimmer-biomet-holdings-inc-zbh.html.

In other news, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.07% of the stock is owned by company insiders.

ZBH has been the topic of several research reports. Zacks Investment Research cut Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 8th. Morgan Stanley lifted their target price on Zimmer Biomet Holdings from $137.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, July 17th. Oppenheimer Holdings, Inc. set a $137.00 target price on Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Monday, August 14th. Canaccord Genuity reaffirmed a “buy” rating and issued a $141.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Finally, Needham & Company LLC reaffirmed a “strong-buy” rating and issued a $153.00 target price on shares of Zimmer Biomet Holdings in a report on Wednesday, July 12th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $136.75.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.